InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

SE

Shaff Eric D.

US·SEC (Form 4)

Seres Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

T+90 hit rate

67%

T+90 mean return

+34.2%

Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by Shaff Eric D.. Director active across 1 company, notably Seres Therapeutics, Inc.. Aggregated, 9 filings have been published. Activity tracked since 5 July 2022. The latest transaction was filed on 27 October 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.

Declarations9 total

◇

CEO and PresidentExecutives15 May 2025Seres Therapeutics, Inc.

390 sharesCommon StockSEC:0000950170-25-074327:0

◇

CEO and PresidentExecutives15 Feb 2025Seres Therapeutics, Inc.

7,813 sharesCommon StockSEC:0000950170-25-023575:0

◇

CEO and PresidentExecutives15 Nov 2024Seres Therapeutics, Inc.

7,812 sharesCommon StockSEC:0000950170-24-128609:0

◇

CEO and PresidentExecutives27 Oct 2024Seres Therapeutics, Inc.

27,837 shares0Common StockSEC:0000950170-24-118409:0

◇

CEO and PresidentExecutives15 Aug 2024Seres Therapeutics, Inc.

7,813 sharesCommon StockSEC:0000950170-24-098712:0

◇

CEO and PresidentExecutives15 May 2024Seres Therapeutics, Inc.

7,812 sharesCommon StockSEC:0000950170-24-062059:0

◇

CEO and PresidentExecutives15 Feb 2024Seres Therapeutics, Inc.

31,250 sharesCommon StockSEC:0000950170-24-016710:0

◇

CEO and PresidentExecutives27 Oct 2023Seres Therapeutics, Inc.

27,838 shares0Common StockSEC:0000899243-23-020080:0

◆

CEO and PresidentExecutives5 Jul 2022Seres Therapeutics, Inc.

$200,00030SEC ↗

63,492 shares@ US$3.15100.0% of flowCOMMON STOCKSEC:0000899243-22-025509:0

9 of 9 declarations